India Nonalcoholic Steatohepatitis Therapeutics Market (2025-2031) | Analysis, Competitive Landscape, Forecast, Companies, Segmentation, Trends, Share, Growth, Industry, Size & Revenue, Value, Outlook

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 India Country Macro Economic Indicators

3.2 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 India Nonalcoholic Steatohepatitis Therapeutics Market - Industry Life Cycle

3.4 India Nonalcoholic Steatohepatitis Therapeutics Market - Porter's Five Forces

3.5 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume Share, By Drug Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of nonalcoholic steatohepatitis (NASH) in India

4.2.2 Rising awareness about the disease and available treatment options

4.2.3 Growing healthcare infrastructure and investment in research and development

4.3 Market Restraints

4.3.1 High cost associated with NASH therapeutics

4.3.2 Lack of effective treatment options for NASH in India

4.3.3 Regulatory challenges and delays in drug approvals

6.1 India Nonalcoholic Steatohepatitis Therapeutics Market, By Drug Type

6.1.1 Overview and Analysis

6.1.2 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Drug Type, 2021- 2031F

6.1.3 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Obeticholic Acid (OCA), 2021- 2031F

6.1.4 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Aramchol (Arachidyl Amido Cholanoic Acid), 2021- 2031F

6.1.5 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Saroglitazar, 2021- 2031F

6.1.6 India Nonalcoholic Steatohepatitis Therapeutics Market Revenues & Volume, By Elafibranor, 2021- 2031F

7.1 India Nonalcoholic Steatohepatitis Therapeutics Market Export to Major Countries

7.2 India Nonalcoholic Steatohepatitis Therapeutics Market Imports from Major Countries

8.1 Patient adherence rate to prescribed NASH therapies

8.2 Percentage of healthcare professionals trained in diagnosing and treating NASH

8.3 Number of clinical trials conducted for NASH treatments in India

9.1 India Nonalcoholic Steatohepatitis Therapeutics Market Opportunity Assessment, By Drug Type, 2021 & 2031F

10.1 India Nonalcoholic Steatohepatitis Therapeutics Market Revenue Share, By Companies, 2024

10.2 India Nonalcoholic Steatohepatitis Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters